Laura E. Niklason - 14 Dec 2021 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
14 Dec 2021
Net transactions value
-$2,729,332
Form type
4
Filing time
16 Dec 2021, 18:46:50 UTC
Previous filing
15 Oct 2021
Next filing
25 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale $232,154 -23,694 -2.9% $9.80 786,467 14 Dec 2021 By spouse F1, F2
transaction HUMA Common Stock Sale $711,553 -76,306 -9.7% $9.32 710,161 14 Dec 2021 By spouse F3
transaction HUMA Common Stock Sale $1,110,625 -125,000 -18% $8.88 585,161 15 Dec 2021 By spouse F4
transaction HUMA Common Stock Sale $675,000 -75,000 -13% $9.00 510,161 16 Dec 2021 By spouse F5
holding HUMA Common Stock 20,452,504 14 Dec 2021 By Ayabudge LLC
holding HUMA Common Stock 1,148,240 14 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A portion of this sale is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the purchase by Ayabudge LLC of 1,522,500 shares of the Issuer's common stock on August 26, 2021, at a price per share of $10.00. The Reporting Person's spouse has paid the Issuer $71.21, representing the full amount of profit realized in connection with this sale.
F2 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $9.50 to $10.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.825 to $9.49. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.68 to $9.43. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.79 to $9.33. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.